NASDAQ · MASI

Masimo Corporation

$179.95 +$0.01 (+0.01%) 1D
Charting by TradingView

Key Metrics

$7.13B
Market cap
31.30×
P/E · TTM
$31.60M
Revenue · TTM
$227.80M
Net income
EPS · TTM $4.16
Dividend yield —
Free cash flow $210.90M
Beta · 1Y 0.33
EBITDA · TTM $41.20M
Gross margin 53.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 17
    The stock moved +34.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.13B
Enterprise value$7.46B
Shares outstanding53.7M
52-wk range$125.94 – $179.99
Avg volume · 20D677.4K
Net cash −$327.40M
Book value / share$14.40
IndustryElectromedical & Electrotherapeutic Apparatus
ExchangeNASDAQ
About Masimo Corporation
IPO dateAug 8, 2007
Employees3600

Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E31.30
P/S225.67
P/FCF33.81
EV/EBITDA181.03
EV/Sales236.03
Graham №$36.69

Profitability

Gross 53.2%
Operating 9.2%
Net 720.9%
FCF 667.4%
ROE / ROIC 28.9% · 0.2%

Financial Health

Current ratio2.68
Quick ratio1.45
Debt / equity0.57
Debt / EBITDA 10.97
Net cash −$327.40M
Working capital$545.10M

Cash Flow · TTM

Operating CF $232.00M
Capex −$21.10M
Free cash flow $210.90M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

6.6
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$36.69 vs $179.95
Trades 4.9× above classic defensive value — priced for growth
Fundamentals through 2026-04-04 · computed by TickerWolf from SEC filings